Biomarker Card
This biomarker card gives comprehensive information about each biomarker.
| Detailed Information | |
|---|---|
| Biomarker ID | 1566 |
| PMID | 31060542 |
| Year | 2019 |
| Biomarker | TMEFF2 |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Upregulated in PCa (Log 2 Median Centered Intensity) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: Myc repressed pathway |
| Experiment | Primary/Localised Vs Metastatic/CRPC Prostate Cancer |
| Type of Biomarker | Prognostic |
| Cohort | 4 cohorts were used in the dataset. Cohort 1: VANJANA cohort: 8 normal tissues , 27 Primary cancer, and 5 metastatic PCa;VARAMBALLY Cohort (GSE3325): 6 normal tissues , 7 Primary cancer, and 6 CRPC;GRASSO Cohort: (GSE35988): 28 Benign, 59 Localised, 35 CRPC;MSKCC Cohort: (GSE21032): 35 normal tissues , 131 Primary cancer, and 19 metastatic PCa; |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | Microarrays |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | NA |